These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10322406)

  • 21. Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor.
    García A; Alvarez CV; Smith RG; Diéguez C
    Mol Endocrinol; 2001 Sep; 15(9):1484-95. PubMed ID: 11518797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
    Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
    Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone.
    Luque RM; Kineman RD; Park S; Peng XD; Gracia-Navarro F; Castaño JP; Malagon MM
    Endocrinology; 2004 Jul; 145(7):3182-9. PubMed ID: 15044357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine: A partial agonist of the growth hormone secretagogue receptor.
    Smith RG; Griffin PR; Xu Y; Smith AG; Liu K; Calacay J; Feighner SD; Pong C; Leong D; Pomés A; Cheng K; Van der Ploeg LH; Howard AD; Schaeffer J; Leonard RJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1306-13. PubMed ID: 11027627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat.
    Bennett PA; Thomas GB; Howard AD; Feighner SD; van der Ploeg LH; Smith RG; Robinson IC
    Endocrinology; 1997 Nov; 138(11):4552-7. PubMed ID: 9348177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE; Bonomo SM; Cella SG; Müller EE
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone-releasing peptides: clinical and basic aspects.
    Argente J; García-Segura LM; Pozo J; Chowen JA
    Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of retinoic acid on growth hormone-releasing hormone receptor, growth hormone secretagogue receptor gene expression and growth hormone secretion in rat anterior pituitary cells.
    Maliza R; Fujiwara K; Tsukada T; Azuma M; Kikuchi M; Yashiro T
    Endocr J; 2016 Jun; 63(6):555-61. PubMed ID: 27052215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone-releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rats whose expression of ghrelin receptor is attenuated: Evidence that ghrelin receptor is involved in the up-regulation of GHRH expression in the arc.
    Mano-Otagiri A; Nemoto T; Sekino A; Yamauchi N; Shuto Y; Sugihara H; Oikawa S; Shibasaki T
    Endocrinology; 2006 Sep; 147(9):4093-103. PubMed ID: 16728494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686.
    Nagamine J; Nagata R; Seki H; Nomura-Akimaru N; Ueki Y; Kumagai K; Taiji M; Noguchi H
    J Endocrinol; 2001 Dec; 171(3):481-9. PubMed ID: 11739014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
    Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
    Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
    Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
    Kovacs M; Kineman RD; Schally AV; Flerko B; Frohman LA
    J Neuroendocrinol; 2000 Apr; 12(4):335-41. PubMed ID: 10718930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone secretagogues as diagnostic tools in disease states.
    Baldelli R; Otero XL; Camiña JP; Gualillo O; Popovic V; Dieguez C; Casanueva FF
    Endocrine; 2001 Feb; 14(1):95-9. PubMed ID: 11322508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.